The medication operates by diminishing appetite and reducing food intake
Marie-Christine Beauvieux, CNRS Universit Bordeaux, France Copyright 2015 Spreckley and Murphy
107 , djv275 (2015)
By bridging rigorous mechanistic insights with real-world therapeutic applications, we aim to underscore how a deep understanding of GLP-1 biologyspanning metabolic, cardiovascular, inflammatory, and neurohormonal pathwayscan inform more precise, effective, and individualized treatment strategies
It reduced pro-inflammatory cytokines (TNF-, IL-6, IL-1), chemokines, adhesion molecules and oxidative stress, while upregulating the expression of neurotrophic factors (neuritin and NGF) [11]
Burrows T